Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5825771 | Clinical Therapeutics | 2012 | 16 Pages |
Abstract
When current therapy is not adequate to obtain glycemic control, acarbose could be an option as monotherapy and as an add-on to other antidiabetic drug treatment, especially when postprandial hyperglycemia is the main concern. Long-term studies are needed to determine whether the effects observed with acarbose use are maintained over the years.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
Giuseppe MD, PhD, Pamela MD,